Blackpoint Biotech plc, a medical cannabinoids company established to fulfil gaps in the medical cannabis market by creating products that provide fast onset of action and accurate dosing, intends to join intends to join the Access Segment of the AQSE Growth Market. Expected Admission 20 July 2023.
Metals One Plc, a company focusing on acquiring natural resources projects with a focus on critical battery metals, including nickel, lithium, cobalt and copper intends to join the AIM Market. The Company will have interests in the Paltamo and Rautavaara projects (nickel, copper, zinc) in Finland (together the Black Schist Project) and the Brownfield Råna Nickel project in Norway (Brownfield Rana Project). These projects represent opportunities to develop deposits of scale, in stable jurisdictions, well situated to supply fastest growing European electric vehicle and energy storage markets. The Company aims to raise £2.5m at 5 pence per share with an anticipated market cap of £10.77m. Expected Admission date is 17 July 2023.
Ora Technology plc, a software company developing a digital carbon trading platform, offering users the ability to buy, sell and retire verified carbon credits in the voluntary carbon market, intends to join the Access Segment of the AQSE Growth Market. Ora’s platform aims to allow access to carbon assets - and the broader carbon economy - with the goal of reducing the complexity of current industry practices, and an emphasis towards providing a simple and intuitive user experience.
Praetura Growth VCT plc, a newly established VCT announces its intention to float on the Main Market of the London Stock Exchange. The Company will provide growth funding to scalable businesses predominantly based in the North of England, across a range of sectors including technology and healthcare. The Company will be managed by Praetura Ventures Limited, a venture capital and EIS business associated with the wider Praetura Group, a Manchester based venture capital investor and small business lender. The Company is targeting to raise £10m at 1 pence per share, via an offer for subscription. The Directors will have the option to utilise an over-allotment facility that will allow the Company to issue a further 10m Ordinary Shares under the Offer.
CAB Payments Holdings Limited, a market lender to business to business (B2B) cross-border payments and foreign exchange, specialising in emerging markets is joining the Premium Segment of the Main Market on around 11 July. The Group announced revenues of £41.3m for the three months ended 31 March 2023 with the YTD adjusted EBITDA margin at 64%. CAB Payments has set an offer price of 335p per share, which will give it a debut market cap of £851.4m.
Byotrol 2.0p £9.1m (BYOT.L)
The specialist infection prevention and control company, reports the approval of a UK patent following its discovery of unique anti-viral properties of certain enhanced extracts of commonly available brown seaweed. The award has been supported by the scientists at the University of Liverpool led by Professor James Stewart, and by funding received from the Biotechnology and Biological Sciences Research Council (BBSRC) and Innovate UK. The grant of the patent application gives Byotrol validated, valuable and protected intellectual property, to support the development of commercial relationships.
Canadian Overseas Petroleum 2.05p £11.8m (COPL.L)
The international oil and gas exploration, production and development company with operations focused in Converse and Natrona counties, Wyoming, USA, provides an update on its operations. Oil Production in Q2 rebounded to an average 1,250 Bbl./d, with production for the month of June averaging 1,249 Bbl./d following pipelining at the Company’s Barron Flats Shannon Unit (BFSU) which caused intermittent interruptions in injection volumes and production volumes. Construction of the BFSU’s $4.5m high-pressure gas gathering system upgrade is on target for completion this month as previously disclosed. Three conversions of BFSU flowing wells to pumping-flowing wells have been completed and performance has been within expectations.
Distil 0.45p £3.1m (DIS.L)
The owner of premium drinks RedLeg Spiced Rum, Blackwoods Gin and Vodka, TRØVE Botanical Vodka, Blavod Black Vodka and Diva Vodka, provides a trading update on the first quarter (April - June 2023) of its current financial year. Revenues increased 206% from £119k to £364k year-on-year. The business remodel has given the team greater control of its marketing investment, and as a result, marketing investment decreased 72% year-on-year. This quarter RedLeg Spiced Rum activated directly with consumers at two key UK consumer events, The Great Escape Festival in Brighton (80,000 attendees), and Taste of London in Regents Park (55,000 attendees). This quarter also saw the successful launch of the RedLeg e-commerce site which allows Distil to sell directly to consumers online, delivering a new revenue stream for the business.
Ferrexpo 89.18p £533.4m (FXPO.L)
The premium iron ore pellet producer and exporter to the global steel industry, with operations in central Ukraine, and customers across Europe and Asia, reports production results for the second quarter (2Q 2023) and six months to the end of June 2023. The Group successfully operated two pelletiser lines, the second which was recommissioned earlier in the year, ramping up to add flexibility and capacity. Total iron ore pellet production for 2Q 2023 was 1,066m tonnes, 18% higher compared to the previous quarter, and for the 1H 2023 1,967m tonnes, a 57% increase compared to 2H 2022. Sales continued to be exported by rail and barge to Central-Eastern Europe, and the Black Sea. Sales for the quarter totalled 1.2m tonnes, 45% higher than the previous quarter, and 2.1m tonnes for 1H 2023, a 15% increase compared to 2H 2022.
Gelion 27.75p £30.1m (GELN.L)
The Anglo-Australian battery innovator provides an update on the strategic evaluation of its Zinc battery solution and on advances made on its Lithium Sulfur technology. Zinc battery solution: early progress has been made on the anode side, with improved system behaviour. However, the R&D Programme also identified potential safety concerns on the cathode side. As a result, Gelion is migrating to a zinc solution that avoids the potential safety concerns. Gelion expects to validate the potential of this technology over the next six months and report back in early 2024, keeping in line with the timelines communicated for the current R&D Programme. Lithium Sulfur: Gelion intends to increase the testing capacity of its R&D facilities by 50% in regard to the potential of intellectual property packages acquired from Johnson Matthey when combined with Gelion's existing technologies. The site will have the capability to increase Gelion's prototyping toward cell development and is due to be operational in September 2023.
Golden Metal Resources 8.75p £7.4m (GMET.L)
The mineral exploration company focused on tungsten, gold, copper and silver within Nevada, USA, announces the Company has staked claims over a significant footprint within the Kibby Basin, where lithium brine discoveries were recently made. The claims acquired sit very near to the Company's 100% owned flagship Pilot Mountain Project located within the prolific Walker Lake Mineral Belt in Nevada, USA. Nevada is a well-established lithium jurisdiction which hosts some of the United States and the world's largest lithium deposits including Thacker Pass and Silver Peak. Within the State, lithium is found predominantly within brines and clays.
Horizonte Minerals 158p £424.7m (HZM.L)
The nickel company developing two Tier 1 assets in Brazil, announces that it has received its mining approval permit for its 100%-owned Araguaia Nickel Project. The approval was issued by the Pará State Secretariat for Environment and Sustainability and enables Horizonte to commence its mining activities, with initial work underway to establish ore stockpiles on the ROM pad ahead of the commissioning phase. Over the course of the next six months, stockpiles will be established, with sufficient ore to feed the plant for the subsequent six months. The Pequizeiro Pit, located 750 metres from the plant site, will be the primary source of ore to Araguaia, supplying the first two years of the Project’s mine life and contributing over 50% of the mine production for the first ten years.
STV Group 234p £109.3m (STVG.L)
The Scottish digital media brand announces it has acquired, through its wholly-owned subsidiary STV Studios Limited, 100% of the issued share capital of unscripted television production network Greenbird Media Limited for a total cash consideration of approximately £24m, of which £21.4m was paid on completion. The acquisition will make STV Studios one of the largest production groups in the UK, and is major step towards its objective of becoming the UK's No.1 nations & regions producer. An initial cash payment of £21.4m includes £11.5m for the repayment of loan notes to Keshet at completion, a cash adjustment of £0.3m, and the balance payable to the existing shareholders, equivalent to 86% of the equity, including Keshet's entire equity interest. Deferred consideration in relation to the balance of 14% of the equity is payable to the Founders based on agreed EBITDA targets over the 2 years ending 31 December 2024.The remaining consideration of c.£1m relates to surplus cash balances held by the majority companies at completion.
TPXimpact Holdings 34.5p £31.8m (TPX.L)
The technology-enabled services company focused on people-powered transformation, announces its unaudited results for the year ended 31 March 2023. Performance is in line with market consensus. Revenue increased 5.0% to £83.7m (2022: £79.7m) and Adjusted EBITDA decreased to £2.5m (2022: £12.2m). The Company reported an operating loss of £19.4m (2022: operating profit of £3.2m), after including £11.8m non-cash impairment charge for goodwill/ intangible assets. Post period, trading for the first two months of FY24 has been in line with management expectations, with like-for-like revenue growth of over 5%. With over £80m of FY24 revenues represented by committed spend, the Group’s FY24 outlook remains unchanged with like-for-like revenue growth of 15-20% and adjusted EBITDA margins of 5-6%.
Virgin Wines 29p £16.2m (VINO.L)
The UK direct-to-consumer online wine retailers, announces it has signed a new strategic partnership with WH Smith Travel, one of the UK's leading travel retailers and part of WH Smith plc. The agreement represents progress for Virgin Wines as part of the Group's strategic focus on commercial partnerships. The exclusively curated range of quality wines is now stocked across 39 WH Smith stores within airports and train stations nationwide. Virgin Wines continues to explore additional potential value accretive partnerships, following others recently agreed with British brands including Saga, Moonpig and Currys.
Disclaimer
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@chrish351.sg-host.com with “unsubscribe me”.
